Intermittent Fasting (IF) as a means of dietary modification has gained popularity among individuals with obesity as a means of achieving weight loss. Especially within recent years, the utility of IF has grown in patients with metabolic syndrome, pre-diabetes and type 2 diabetes mellitus (T2DM). The focus of this presentation will be the utility of IF regimens as a means of weight loss in patients with T2DM using hypoglycemic agents. Dr. Rajpal will discuss and suggest preventive measures to minimize the adverse effects of IF regimens in this special population. CME/CE Expiration Date: 10/28/26 *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
- Provider:Obesity Medicine Association
- Activity Link: https://academy.obesitymedicine.org/node/5476
- Start Date: 2023-10-28 05:00:00
- End Date: 2023-10-28 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest